Hiv/Aids Testing

Summary

Revolutionary developments in the field of HIV disease monitoring and management have had its direct impact on HIV testing market. Earlier considered a life threatening disease, HIV/AIDS has now emerged as a persistent condition that necessitates efficient disease management. Such a change has encouraged people to increasingly adopt HIV testing procedures, though the trend is pronounced in developed countries, and is gaining momentum in developing nations. Revolutionary changes in HIV disease monitoring and management have had a significant influence on the HIV testing market. New disease-progression study techniques such as genotyping and phenotyping, and advancements in viral load monitoring tests have significantly improved therapies offered to HIV/AIDS infected individuals.

These and other market data and trends are presented in "HIV/AIDS Testing: World Review" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Global Market Overview and Outlook
  • Majority of Hiv Infections Seen in Developing Countries
  • Hiv/Aids Monitoring Market
  • Growth Drivers
  • Rapid Testing- Displays High Potential
  • Molecular Diagnostics Register Strong Growth in Blood Screening Markets
  • Ultra-Rapid Hiv-Screening Tests- A Strong Fight against Hiv-Epidemic
  • Emergency Room Testing to Help Hiv Diagnosis
  • Otc Hiv Tests to See The Light?
  • Leading Players
  • Fda Approved Rapid Test Kits
  • Hiv/Aids Diagnostics Market Participants - Product Matrix
• 3.Aids: A Global Epidemic
  • Facts & Figures
  • Aids - A Serious Threat
  • Catching Them Young
  • Estimated Number of New Hiv Infections in Young People
  • Anti-Aids Therapeutics: A Blessing in Disguise in Developed Countries
• 4.Product Facts
  • Hiv/Aids Screening Tests
  • Hiv/Aids Confirmatory Tests
  • Hiv/Aids Monitoring Tests
• 5.Technology Review
  • Pcr: A Promising Development in Hiv/Aids Monitoring Market
  • DNA Probes Are Highly Specific and Sensitive
  • Oca-Particles Based Detection System- Offers Increased Accuracy
  • Home Hiv Tests: Unfolding A New Era of Testing
  • Yet Nascent
  • Not without Share of Objections
  • Home Access: Monopolizing The Home Hiv Test Kit Market
• 6.Regulations
  • Overview
  • Un's Testing Policies in Peacekeeping Force
  • Anonymous Versus Confidential Diagnostic Testing for Hiv Infection in US
  • Regulatory Approval for Rapid Hiv Test Kits in US
  • Hiv Testing - Mandatory in US Blood Banks
• 7.Corporate Developments
  • Medmira Bags Supply Contract from Paho
  • Medmira Seeks Patent for Latest Rapid Test Platform
  • Abbott Attains Supplemental Fda Approval for Realtime Hiv-1 Viral Load Test
  • Uscdc Awards Federal Grant to District of Columbia for Hiv Testing
  • Premier Includes Roche Cobas Hiv-1 Monitoring Test in Contract
  • Medmira Receives Usaid Approval for Reveal G3 Rapid Hiv Test
  • Calypte Biomedical Inks Agreement with Fusion Capital
  • Roche Inks Agreement with Clinton Foundation
  • Ortho-Clinical Attains Fda Approval for Hiv Test
  • Geneart Awarded Patent for Hiv Vaccine
  • Crucell's Adenovirus Vector Enters Phase I Clinical Studies
  • Medmira to Expand Operations in Eastern Europe
  • Calypte Initiates Sale of AwareHiv-1/2 Omt Oral Fluid Test in India
  • Calypte Receives Approval for Aware Hiv-1/2 Omt Test
  • Bundi Opts for Surgilance Safety Lancet
  • Chembio Diagnostics Receives Sublicense for Hiv-2 Patent
  • Calypte Launches Aware Messenger/li>
  • Calypte Receives Usaid Approval
  • Roche's Latest Hiv-1 Test Receives Fda Approval
  • Oraquick Advance Becomes Preferred Hiv Test Kit in Philadelphia
  • Beckman Coulter Receives Grant
  • Oregon Medical Adopts Roche Diagnostics' Hiv Test
  • Orasure Inks Agreement with Supply Chain Management System
  • Bio-Rad Enters into Multi-Year Agreements with Quest Diagnostics
  • Cytodyn Pockets Advanced Genetic Technologies
  • Aethlon Partners with Imquest
  • Quest Diagnostics Receives License from Pathway
  • Orasure Inks Agreement with Constella Group
  • Labcorp to Offer Fully Automated Real-Time Hiv Test of Roche Diagnostics
  • Abbott Receives Fda Approval for Realtime Hiv-1 Test
  • Abbott Receives Health Canada Approval
  • Novartis Receives Health Canada Approval
  • Medical Services Completes Trials of Vscan Hepatitis C and Hiv Test Kit
  • Health Canada Approves Versant 440 Molecular Systems
  • Orasure Receives Ce Mark for Oraquick Advance Hiv Test
  • Medmira Receives Approval for Multiplo Hbv/Hiv/Hcv
  • Roche Diagnostics Partners with Ark Diagnostics
  • Roche' Hiv Viral Load Test Used in Clinical Trials
  • Innogenetics and Bio-Rad Ink Licensing Agreement
  • Orasure Bags Contract from Madagascar Government
  • Calypte Receives Approval for Aware(Tm) Hiv-1/2 Omt Rapid Test
  • Siemens Acquires Bayer Diagnostics
  • Abbott Launches Advanced Viral Load Test
  • Medmira Launches MiracareRapid Tests with Extended Shelf Life
  • University Researcher Develops Novel Hiv/Aids Antibody Test Kit
  • Biomrieux Introduces Vikia Hiv 1 / 2 Rapid Hiv Test
  • Dr Lal Pathlabs Develops Inexpensive Hiv Monitoring Test
• 8.Major Players
  • Abbott Laboratories, Inc. (USA)
  • Abbott Molecular, Inc. (USA)
  • Adaltis, Inc. (Canada)
  • Siemens Healthcare Diagnostics, Inc. (USA)
  • Biomrieux Sa (France)
  • Bio-Rad Laboratories, Inc. (USA)
  • Calypte Biomedical Corporation (USA)
  • Celera Group (USA)
  • Gen-Probe Inc. (USA)
  • Innogenetics Nv (Belgium)
  • Medmira Laboratories, Inc. (Canada)
  • Medical Services International Inc. (Canada)
  • Orasure Technologies Inc. (USA)
  • Ortho-Clinical Diagnostics Inc. (USA)
  • Roche Diagnostics (Switzerland)
• 9.Market Analytics
• 10.The United States
  • Market Overview
  • Competitive Structure
  • Rapid Hiv Tests... Display Rapid Growth
  • Leading Players
  • Fda Approved Rapid Test Kits
  • Nat Tests Score High in Blood Banks
  • Major End-Users of Hiv/Aids Tests
  • Hiv Testing Made Mandatory in Blood Banks
  • Physician and Public Health Clinical Market
  • Home Hiv Tests
  • Efforts by Organizations
  • Vermont Department of Health Suggests Hiv Screening for Pregnant Women
• 11.Canada
  • Hiv Statistics
  • Hiv Incidence among Women
• 12.Japan
  • Hiv in Japan
• 13.Europe
  • A.France
  • B.Germany
  • C.Italy
  • D.The United Kingdom
  • E.Spain
  • F.Rest of Europe
• 14.Asia-Pacific
  • The next Epicenter for The Aids Epidemic
  • China and India: The Worst Affected
  • Review of Select Asian Countries
  • Australia
  • Thailand
  • Hiv Cases on Decline
  • Vietnam
• 15.Latin America
  • Epidemics of Hiv in Latin America
• 16.Rest of World
  • Africa
  • Facing The Brunt of The Disease
  • Tanzania to Implement Second Phase of National Program for Hiv/Aids Testing
  • South Africa - The Hiv/Aids Hub
  • Uganda - A Review
• Exhibits
  • Table 1: Hiv/Aids Cases in Adults and Children Worldwide: Breakdown by Region-End
  • Table 2: Global Hiv/Aids Testing Market by Region for The Period 2007-2015 (Sales in Thousand Units)
  • Table 3: Percentage Breakdown (Unit Sales) of Global Hiv/Aids Testing Market by Region for The Years 2008 &
  • Table 4: Global Hiv/Aids Screening Tests Market by Region for The Period 2007-2015 (Sales in Thousand Units)
  • Table 5: Percentage Breakdown (Unit Sales) of Global Hiv/Aids Screening Tests Market by Region for The Years 2008 &
  • Table 6: Global Hiv/Aids Confirmatory Tests Market by Region for The Period 2007-2015 (Sales in Thousand Units)
  • Table 7: Percentage Breakdown (Unit Sales) of Global Hiv/Aids Confirmatory Tests Market by Region for The Years 2008 &
  • Table 8: Global Hiv/Aids Testing Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 9: Percentage Breakdown (Dollar Sales) of Global Hiv/Aids Testing Market by Region for The Years 2008 &
  • Table 10: Global Hiv/Aids Screening Tests Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 11: Percentage Breakdown (Dollar Sales) of Global Hiv/Aids Screening Tests Market by Region for The Years 2008 &
  • Table 12: Global Hiv/Aids Confirmatory Tests Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 13: Percentage Breakdown (Dollar Sales) of Global Hiv/Aids Confirmatory Tests Market by Region for The Years 2008 &
  • Table 14: Global Hiv/Aids Monitoring Tests Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 15: Percentage Breakdown (Dollar Sales) of Global Hiv/Aids Monitoring Tests Market by Region for The Years 2008 &
  • Table 16: Market Shares of Leading Hiv Diagnostics Manufacturers in The US -
  • Table 17: Market Shares of Leading Hiv Viral Load Testing Equipment Manufacturers in The US -
  • Table 18: Percentage of Hiv/Aids Cases in The US, by Gender: 1993
  • Table 19: Hiv/Aids Testing Market by Segment in The US: 2007-2015 (Sales in Thousand Units)
  • Table 20: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in The US for The Years 2008 &
  • Table 21: Hiv/Aids Testing Market by Segment in The US: 2007-2015 (Sales in US$ Million)
  • Table 22: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in The US for The Years 2008 &
  • Table 23: Aids/ Hiv Diagnosis Trend in Canada: 2005
  • Table 24: Aids and Positive Hiv Cases in Canada by Age Group: 2006-End
  • Table 25: Hiv/Aids Testing Market by Segment in Canada: 2007-2015 (Sales in Thousand Units)
  • Table 26: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Canada for The Years 2008 &
  • Table 27: Hiv/Aids Testing Market by Segment in Canada: 2007-2015 (Sales in US$ Million)
  • Table 28: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Canada for The Years 2008 &
  • Table 29: Hiv/Aids Testing Market by Segment in Japan: 2007-2015 (Sales in Thousand Units)
  • Table 30: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Japan for The Years 2008 &
  • Table 31: Hiv/Aids Testing Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
  • Table 32: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Japan for The Years 2008 &
  • Table 33: Hiv Diagnosis in Western Europe: Facts and Figures by Country (2006)
  • Table 34: Hiv Diagnosis in Central Europe: Facts and Figures by Country (2006)
  • Table 35: Hiv Diagnosis in Eastern Europe: Facts and Figures by Country (2006)
  • Table 36: Hiv/Aids Testing Market by Region in Europe: 2007-2015 (Sales in Thousand Units)
  • Table 37: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Region in Europe for The Years 2008 &
  • Table 38: Hiv/Aids Testing Market by Segment in Europe: 2007-2015 (Sales in Thousand Units)
  • Table 39: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Europe for The Years 2008 &
  • Table 40: Hiv/Aids Testing Market by Region in Europe: 2007-2015 (Sales in US$ Million)
  • Table 41: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Region in Europe for The Years 2008 &
  • Table 42: Hiv/Aids Testing Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
  • Table 43: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Europe for The Years 2008 &
  • Table 44: Hiv/Aids Testing Market by Segment in France: 2007-2015 (Sales in Thousand Units)
  • Table 45: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in France for The Years 2008 &
  • Table 46: Hiv/Aids Testing Market by Segment in France: 2007-2015 (Sales in US$ Million)
  • Table 47: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in France for The Years 2008 &
  • Table 48: Hiv/Aids Testing Market by Segment in Germany: 2007-2015 (Sales in Thousand Units)
  • Table 49: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Germany for The Years 2008 &
  • Table 50: Hiv/Aids Testing Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
  • Table 51: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Germany for The Years 2008 &
  • Table 52: Hiv/Aids Prevalence and Mortality Rates by Age Group in Italy: End of
  • Table 53: Hiv/Aids Testing Market by Segment in Italy: 2007-2015 (Sales in Thousand Units)
  • Table 54: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Italy for The Years 2008 &
  • Table 55: Hiv/Aids Testing Market by Segment in Italy: 2007-2015 (Sales in US$ Million)
  • Table 56: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Italy for The Years 2008 &
  • Table 57: Hiv/Aids Testing Market by Segment in The UK: 2007-2015 (Sales in Thousand Units)
  • Table 58: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in The UK for The Years 2008 &
  • Table 59: Hiv/Aids Testing Market by Segment in The UK: 2007-2015 (Sales in US$ Million)
  • Table 60: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in The UK for The Years 2008 &
  • Table 61: Hiv/Aids Testing Market by Segment in Spain: 2007-2015 (Sales in Thousand Units)
  • Table 62: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Spain for The Years 2008 &
  • Table 63: Hiv/Aids Testing Market by Segment in Spain: 2007-2015 (Sales in US$ Million)
  • Table 64: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Spain for The Years 2008 &
  • Table 65: Hiv/Aids Testing Market by Segment in Rest of Europe: 2007-2015 (Sales in Thousand Units)
  • Table 66: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Rest of Europe for The Years 2008 &
  • Table 67: Hiv/Aids Testing Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
  • Table 68: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Rest of Europe for The Years 2008 &
  • Table 69: Number of Hiv and Aids Cases in Australia: 2004 to
  • Table 70: Estimated Living Population in India with Hiv/Aids Infection (2007): Breakdown by Group (in '000)
  • Table 71: Number of Live Persons Infection with Hiv in Thailand: 2005-End
  • Table 72: Hiv/Aids Testing Market by Segment in Asia Pacific: 2007-2015 (Sales in Thousand Units)
  • Table 73: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Asia Pacific for The Years 2008 &
  • Table 74: Hiv/Aids Testing Market by Segment in Asia Pacific: 2007-2015 (Sales in US$ Million)
  • Table 75: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Asia Pacific for The Years 2008 &
  • Table 76: People Living with Hiv Infection in Latin America by Country: 2005 (in Thousands)
  • Table 77: Hiv/Aids Testing Market by Segment in Latin America: 2007-2015 (Sales in Thousand Units)
  • Table 78: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Latin America for The Years 2008 &
  • Table 79: Hiv/Aids Testing Market by Segment in Latin America: 2007-2015 (Sales in US$ Million)
  • Table 80: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Latin America for The Years 2008 &
  • Table 81: Hiv/Aids Cases in Africa as of 2005-End: Breakdown by Top 20 Countries
  • Table 82: Hiv/Aids Prevalence Rates in Caribbean Nations till End of
  • Table 83: Hiv/Aids Testing Market by Segment in Rest of World: 2007-2015 (Sales in Thousand Units)
  • Table 84: Percentage Breakdown (Unit Sales) of Hiv/Aids Testing Market by Segment in Rest of World for The Years 2008 &
  • Table 85: Hiv/Aids Testing Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
  • Table 86: Percentage Breakdown (Dollar Sales) of Hiv/Aids Testing Market by Segment in Rest of World for The Years 2008 &
• Companies Profiled